home / stock / lxxgf / lxxgf quote
Last: | $0.0806 |
---|---|
Change Percent: | -6.7% |
Open: | $0.086 |
Close: | $0.0806 |
High: | $0.105 |
Low: | $0.074 |
Volume: | 1,417,642 |
Last Trade Date Time: | 02/21/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0806 | $0.086 | $0.0806 | $0.105 | $0.074 | 1,417,642 | 02-21-2023 |
$0.0965 | $0.105 | $0.0965 | $0.126 | $0.095 | 1,413,028 | 02-20-2023 |
$0.0965 | $0.105 | $0.0965 | $0.126 | $0.095 | 1,413,028 | 02-17-2023 |
$0.1098 | $0.167 | $0.1098 | $0.167 | $0.1 | 3,514,878 | 02-16-2023 |
$0.17 | $0.1664 | $0.17 | $0.172 | $0.1557 | 49,933 | 02-15-2023 |
$0.1699 | $0.172 | $0.1699 | $0.1839 | $0.165 | 165,030 | 02-14-2023 |
$0.182 | $0.1883 | $0.182 | $0.1929 | $0.1691 | 9,527 | 02-13-2023 |
$0.188 | $0.16965 | $0.188 | $0.189 | $0.16965 | 185,050 | 02-10-2023 |
$0.1767 | $0.178 | $0.1767 | $0.1852 | $0.16774 | 67,066 | 02-09-2023 |
$0.174 | $0.17395 | $0.174 | $0.1823 | $0.17001 | 110,553 | 02-08-2023 |
$0.1754 | $0.175 | $0.1754 | $0.1755 | $0.1601 | 118,948 | 02-07-2023 |
$0.1744 | $0.1749 | $0.1744 | $0.1749 | $0.168 | 59,692 | 02-06-2023 |
$0.1749 | $0.17 | $0.1749 | $0.17504 | $0.17 | 104,980 | 02-03-2023 |
$0.1742 | $0.172 | $0.1742 | $0.1742 | $0.1635 | 107,408 | 02-02-2023 |
$0.17325 | $0.16172 | $0.17325 | $0.185 | $0.16172 | 120,009 | 02-01-2023 |
$0.1845 | $0.1783 | $0.1845 | $0.1856 | $0.1727 | 175,078 | 01-31-2023 |
$0.1815 | $0.1997 | $0.1815 | $0.1997 | $0.1787 | 222,148 | 01-30-2023 |
$0.203 | $0.203 | $0.203 | $0.203 | $0.201 | 31,395 | 01-27-2023 |
$0.203 | $0.2044 | $0.203 | $0.2044 | $0.20194 | 110,903 | 01-26-2023 |
$0.20195 | $0.2 | $0.20195 | $0.206 | $0.19 | 246,317 | 01-25-2023 |
News, Short Squeeze, Breakout and More Instantly...
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...
BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...